Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

BACKGROUND: Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) is the recommended approach in patients with advanced epithelial ovarian cancer (EOC). However, most patients eventually relapse despite the initial high response rate to chemotherapy. Neutrophil-to-lymphocyte r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liontos, M., Andrikopoulou, A., Koutsoukos, K., Markellos, C., Skafida, E., Fiste, O., Kaparelou, M., Thomakos, N., Haidopoulos, D., Rodolakis, A., Dimopoulos, M. A., Zagouri, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561989/
https://www.ncbi.nlm.nih.gov/pubmed/34724958
http://dx.doi.org/10.1186/s13048-021-00902-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561989/
https://www.ncbi.nlm.nih.gov/pubmed/34724958
http://dx.doi.org/10.1186/s13048-021-00902-0

Ejemplares similares